Loading viewer...
report
Format: PDF report
This report presents interim results from an open-label extension study of Antolimab for treating Eosinophilic Gastritis and Duodenitis, highlighting its investigational status.
presentation
report
Hyundai
report
Prowly
report
Expro Group
report
Apptica